# FDA Inspection 637417 - Integrated Commercialization Solutions, Inc. - January 06, 2010

Source: https://www.keypedia.com/records/fda_inspections/integrated-commercialization-solutions-inc/ade9ec81-b2b8-423d-987a-8c01de991492
Source feed: FDA_Inspections

> FDA Inspection 637417 for Integrated Commercialization Solutions, Inc. on January 06, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 637417
- Company Name: Integrated Commercialization Solutions, Inc.
- Inspection Date: 2010-01-06
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1286868 - 2025-09-23](https://www.keypedia.com/records/fda_inspections/integrated-commercialization-solutions-inc/34e54dd7-fe67-4da7-b2c6-50d9bc76d8c3)
- [FDA Inspection 1286868 - 2025-09-23](https://www.keypedia.com/records/fda_inspections/integrated-commercialization-solutions-inc/71304e56-569f-4218-8d0a-511bd99c4ab0)
- [FDA Inspection 1037912 - 2018-01-18](https://www.keypedia.com/records/fda_inspections/integrated-commercialization-solutions-inc/d1810abe-5715-434c-a2c9-f60bdee02a67)

Company: https://www.keypedia.com/companies/integrated-commercialization-solutions-inc/86c598b4-9604-4954-bfa0-90eb8ab14a0c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d